Conditions: Cervical Cancer

Intervention Type: Biological

Intervention Names

The following are clinical trials from the Healia Clinical Trials Information Database related to "Cervical Cancer" that are researching the effect of "Biological" interventions organized by the name of the intervention.

• Cervical Cancer - Biological - HspE7 (3 documents)
• Cervical Cancer - Biological - Comparator: Placebo (unspecified) (2 documents)
• Cervical Cancer - Biological - SS1(dsFv)-PE38 immunotoxin (2 documents)
• Cervical Cancer - Biological - Cervarix TM (HPV-16/18 L1 VLP AS04) (1 documents)
• Cervical Cancer - Biological - Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL���) (1 documents)
• Cervical Cancer - Biological - Comparator: V503 (1 documents)
• Cervical Cancer - Biological - Comparator: octavalent HPV Vaccine - dose formulation 3 (1 documents)
• Cervical Cancer - Biological - Comparator: placebo (concomitant-vaccine matched) / Duration of Treatment : 4 Years (1 documents)
• Cervical Cancer - Biological - GSK Bio's HPV vaccine 580299 (Cervarix TM) (1 documents)
• Cervical Cancer - Biological - GSK Biologicals' HPV vaccine 580299 (1 documents)
• Cervical Cancer - Biological - Gardasil (1 documents)
• Cervical Cancer - Biological - Gardasil (VLP, HPV Quadrivalent prophylactic vaccine) (1 documents)
• Cervical Cancer - Biological - Gardasil�� HPV vaccine (1 documents)
• Cervical Cancer - Biological - HBV vaccine (1 documents)
• Cervical Cancer - Biological - HPV (Human Papillomavirus) Vaccine (1 documents)
• Cervical Cancer - Biological - HPV Vaccine (Gardasil) (1 documents)
• Cervical Cancer - Biological - HPV-16/18 VLP/AS04 Vaccine (Cervarix TM) (1 documents)
• Cervical Cancer - Biological - HPV16 E7 peptide-pulsed autologous DCs (1 documents)
• Cervical Cancer - Biological - Human Papillomavirus (HPV) 16 Monovalent (1 documents)
• Cervical Cancer - Biological - Matching Placebo (1 documents)
• Cervical Cancer - Biological - Placebo (1 documents)
• Cervical Cancer - Biological - Prophylactic quadrivalent HPV vaccine Merck (Gardasil��) (1 documents)
• Cervical Cancer - Biological - Quadrivalent HPV for types 6, 11, 16 and 18 (1 documents)
• Cervical Cancer - Biological - Survivin peptide vaccine (1 documents)
• Cervical Cancer - Biological - V501 (1 documents)
• Cervical Cancer - Biological - V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine (1 documents)
• Cervical Cancer - Biological - V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years (1 documents)
• Cervical Cancer - Biological - V502 (1 documents)
• Cervical Cancer - Biological - bevacizumab (1 documents)
• Cervical Cancer - Biological - cetuximab (1 documents)
• Cervical Cancer - Biological - human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine (1 documents)
• Cervical Cancer - Biological - pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine (1 documents)
• Cervical Cancer - Biological - recombinant interleukin-12 (1 documents)
• Cervical Cancer - Biological - synthetic human papillomavirus 16 E6 peptide (1 documents)
• Cervical Cancer - Biological - therapeutic tumor infiltrating lymphocytes (1 documents)

---